No Broad Autism Approval for Leucovorin, Despite FDA Commissioner’s Prior Suggestions
The Food and Drug Administration on March 10 changed the approval for a version of the prescription drug leucovorin to include people with a very rare genetic condition. FDA Commissioner Dr. Marty Makary had previously implied that the drug’s new label would cover a much broader group of people with autism, sayingContinue Reading












